JP2008509939A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509939A5
JP2008509939A5 JP2007526180A JP2007526180A JP2008509939A5 JP 2008509939 A5 JP2008509939 A5 JP 2008509939A5 JP 2007526180 A JP2007526180 A JP 2007526180A JP 2007526180 A JP2007526180 A JP 2007526180A JP 2008509939 A5 JP2008509939 A5 JP 2008509939A5
Authority
JP
Japan
Prior art keywords
group
compound
compound according
acetate
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007526180A
Other languages
English (en)
Japanese (ja)
Other versions
JP5265915B2 (ja
JP2008509939A (ja
Filing date
Publication date
Priority claimed from US10/921,332 external-priority patent/US7544816B2/en
Application filed filed Critical
Priority claimed from PCT/CN2005/001262 external-priority patent/WO2006017981A1/en
Publication of JP2008509939A publication Critical patent/JP2008509939A/ja
Publication of JP2008509939A5 publication Critical patent/JP2008509939A5/ja
Application granted granted Critical
Publication of JP5265915B2 publication Critical patent/JP5265915B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007526180A 2004-08-19 2005-08-15 プロテアソームを阻害するための(−)−エピガロカテキンガラート誘導体 Expired - Fee Related JP5265915B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/921,332 US7544816B2 (en) 2004-08-19 2004-08-19 (−)-Epigallocatechin gallate derivatives for inhibiting proteasome
US10/921,332 2004-08-19
US64956905P 2005-02-04 2005-02-04
US60/649,569 2005-02-04
PCT/CN2005/001262 WO2006017981A1 (en) 2004-08-19 2005-08-15 (-)-epigallocatechin gallate derivatives for inhibiting proteasome

Publications (3)

Publication Number Publication Date
JP2008509939A JP2008509939A (ja) 2008-04-03
JP2008509939A5 true JP2008509939A5 (https=) 2008-10-02
JP5265915B2 JP5265915B2 (ja) 2013-08-14

Family

ID=35907224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526180A Expired - Fee Related JP5265915B2 (ja) 2004-08-19 2005-08-15 プロテアソームを阻害するための(−)−エピガロカテキンガラート誘導体

Country Status (6)

Country Link
US (4) US8193377B2 (https=)
EP (1) EP1778663B1 (https=)
JP (1) JP5265915B2 (https=)
CN (1) CN101072764B (https=)
ES (1) ES2660339T3 (https=)
WO (1) WO2006017981A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778663B1 (en) 2004-08-19 2017-12-13 The Hong Kong Polytechnic University (-)-epigallocatechin gallate derivatives for inhibiting proteasome
EP2088205A1 (en) 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: A diagnosis marker and therapeutic target of chronic rejection.
US8784873B2 (en) * 2009-07-22 2014-07-22 Naturewise Biotech & Medicals Corporation Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
US9126997B1 (en) 2010-09-07 2015-09-08 Northwestern University Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma
GB2500136B (en) 2010-10-15 2015-02-18 Microsoft Corp Parasitic folded loop antenna
CN102078316A (zh) * 2011-01-24 2011-06-01 广西医科大学 表没食子儿茶素没食子酸酯衍生物在抗肿瘤药物中的应用
CN102153535A (zh) * 2011-03-04 2011-08-17 中国海洋大学 一种抗肿瘤多药耐药抑制剂苯并吡喃-3-醇酯化衍生物及其制备方法和应用
EP2557079A1 (en) * 2011-08-09 2013-02-13 Nestec S.A. Synthesis of catechin and epicatechin conjugates
WO2017132775A1 (en) * 2016-02-05 2017-08-10 Viteava Pharmaceuticals Inc. Novel compositions and methods for the treatment of leiomyoma
CN108129438A (zh) * 2017-12-25 2018-06-08 中国海洋大学 一种含2-苯色满母核的化合物及其制备方法
KR102057773B1 (ko) 2018-03-30 2019-12-19 건국대학교 산학협력단 에피갈로카테킨 갈레이트 유도체를 포함하는 유방암 예방 또는 치료용 약학적 조성물
JP2021527048A (ja) * 2018-06-05 2021-10-11 フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド 癌治療のためのアシル化カテキンポリフェノールおよびその使用方法
CN116162078B (zh) * 2022-12-27 2024-10-29 佛山病原微生物研究院 一种表没食子儿茶素没食子酸酯类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57118580A (en) * 1981-01-16 1982-07-23 Kanebo Ltd Novel catechin derivative
JPS57120584A (en) * 1981-01-20 1982-07-27 Kanebo Ltd Production of catechin derivative
JPH10254087A (ja) * 1997-03-14 1998-09-25 Konica Corp ハロゲン化銀写真感光材料
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US7122573B2 (en) * 2002-12-06 2006-10-17 Sri International Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
US7544816B2 (en) * 2004-08-19 2009-06-09 The Hong Kong Polytechnic University (−)-Epigallocatechin gallate derivatives for inhibiting proteasome
EP1778663B1 (en) * 2004-08-19 2017-12-13 The Hong Kong Polytechnic University (-)-epigallocatechin gallate derivatives for inhibiting proteasome

Similar Documents

Publication Publication Date Title
JP2008509939A5 (https=)
JP2011527299A5 (https=)
EP2090577A3 (en) Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
JP2012502037A5 (https=)
JP2016503793A5 (https=)
EP2305696A3 (en) Macrocyclic inhibitors of Hepatitis C virus replication
WO2007070598A3 (en) Nucleotide and oligonucleotide prodrugs
JP2013509429A5 (https=)
WO2008137779A3 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
EP2620432A3 (en) Diarylhydantoin compounds
EP3091019A3 (en) Purine derivatives useful as hsp90 inhibitors
JP2009545527A5 (https=)
JP2013503846A5 (https=)
JP2013542247A5 (https=)
JP2006524660A5 (https=)
JP2011518833A5 (https=)
JP2014500861A5 (https=)
JP2013508417A5 (https=)
JP2007526331A5 (https=)
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
WO2009134616A3 (en) Novel inhibitors of hepatitis c virus replication
JP2012512863A5 (https=)
JP2014511366A5 (https=)
JP2014516033A5 (https=)
JP2010529994A5 (https=)